Xiaofu Taier Jiaonang (硝呋太尔胶囊)硝呋太尔胶囊
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 北京朗依制药有限公司Chinese legal name: 北京朗依制药有限公司
主要成分Active Ingredients
- 硝呋太尔Xiaofu Taier
药物知识说明
硝呋太尔是一种在国家药监局注册认定的药品。该药品含有硝呋太尔-da5c4a08等成分。
该药品关联的活性成分包括：硝呋太尔Xiaofu Taier。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：北京朗依制药有限公司Chinese legal name: 北京朗依制药有限公司。
您可以探索含有相同成分的其他药品：硝呋太尔-da5c4a08成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 硝呋太尔胶囊) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 硝呋太尔Xiaofu Taier.
Manufacturers recorded for this product: 北京朗依制药有限公司Chinese legal name: 北京朗依制药有限公司.
Explore other medicines containing the same ingredient: 硝呋太尔 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 硝呋太尔胶囊Recorded Chinese name: 硝呋太尔胶囊
- 剂型Dosage form: 胶囊剂Capsules
- 规格Specification: 0.1g*28粒0.1 g × 28 capsules
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 北京朗依制药有限公司Chinese legal name: 北京朗依制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20080299
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20080299
Manufacturer
Chinese legal name: 北京朗依制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
0.1 g × 28 capsules
中文说明书原文Original Chinese source label
批准文号
国药准字H20080299
生产企业
北京朗依制药有限公司(国产)
适应症
1、细菌性阴道病、滴虫性阴道炎、念珠菌性阴道炎以及外阴炎。 2、泌尿系统感染。 3、消化道阿米巴病及贾第虫病。
用法用量
1、阴道感染：每次2粒（200mg），每天3次，连续口服7天。饭后服用。建议夫妻同时服用。 2、泌尿系统感染：成人：6-12粒（600mg-1200mg）/天，平均连续服用1-2周（根据感染的程度和性质而定）。儿童：10-20mg/kg/天；分2次口服，平均连续使用1-2周（根据感染的程度和性质可适当延长）。 3、消化道阿米巴病：成人：每次4粒（400mg），每天3次；连续口服10天。儿童：每次10mg/kg/次；每天2次，连续服用10天。 4、消化道贾第虫病：成人：每次4粒（400mg），每天2-3次；连续口服7天。儿童：每次15mg/kg/次；每天2次，连续服用10天。
不良反应
本品不良反应少见。
禁忌
对硝呋太尔过敏者禁用。
注意事项
使用本品期间请勿饮用酒精饮料，酒精会引起不适或恶心，但这种反应会自行消失。
贮藏
遮光，密闭，干燥处保存。
规格
0.1g*28粒
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.